Skip to main content
. 2021 May 8;259(10):3045–3053. doi: 10.1007/s00417-021-05188-y

Table 1.

Demographic and clinical data of all patients

Data Type of performed glaucoma surgery
TE FCP PMI
Number of patients 187 25 23
Glaucoma diagnosis
  Unilateral/bilateral 6 (3.2%)/181 (96.8%) -/25 (100%) 1 (4.3%)/22 (95.7%)
Operated eye
  Right/left 107 (57.2%)/80 (42.8%) 10 (40%)/15 (60%) 8 (34.8%)/15 (65.2%)
Mean age (range), years 67.1 ± 10.4 (40–88) 60.2 ± 12.6 (35–84) 68.6 ± 13.3 (25–86)
Sex, female/male 96 (51%)/91 (49%) 10 (40%)/15 (60%) 14 (61%)/9 (39%)
Type of glaucoma
  POAG 111 (59%) 18 (72%) 10 (44)
  PEX glaucoma 33 (18%) 3 (12%) 5 (22%)
  NTG 23 (12%) 2 (8%) 6 (26%)
  Pigmentary glaucoma 9 (5%) 2 (8%)
  Secondary uveal glaucoma 7 (4%) 2 (9%)
  Other 4 (2%)
Mean duration of glaucoma, years 8.1 ± 8.5 9.4 ± 6.5 7.6 ± 6.6
Presence of topical therapy in the fellow eye 170 (91%) 24 (96%) 19 (83%)
Surgical status of eye
  Previous laser trabeculoplasty
    Treated eye/fellow eye 22 (12%)/18 (10%) 3 (12%)/3 (12%) 1 (4%)/1 (4%)
  Previous cataract surgery
    Treated eye/fellow eye 75 (40%)/62 (33%) 7 (28%)/6 (24%) 16 (70%)/16 (70%)
  Previous vitreoretinal surgery
    Treated eye/fellow eye 7 (4%)/4 (2%) 1 (4%)/- -/-
    Tmax (mmHg), treated eye/fellow eye 31.1 ± 9/30.6 ± 9 31.8 ± 11.6/32.2 ± 13.1 31.6 ± 10.4/29.7 ± 8.9
    CCT (μm), treated eye/fellow eye 524.6 ± 37.3/526.2 ± 34.3 517.7 ± 29.6/516.6 ± 34.2 527.3 ± 25.5/532.3 ± 25.2
    CDVA, treated eye/fellow eye 0.7 ± 0.3/0.8 ± 0.3 0.7 ± 0.3/0.8 ± 0.2 0.7 ± 0.3/0.7 ± 0.3
    MD (dB), treated eye/fellow eye 12.4 ± 6.9/6.9 ± 5.5 11.7 ± 6.8/7.7 ± 6.7 10.6 ± 5.7/7.2 ± 6.8

TE, trabeculectomy; FCP, filtering canaloplasty; PMI, PreserFloTM microshunt implantation; SD, standard deviation; POAG, primary open angle glaucoma; PEX glaucoma, pseudoexfoliative glaucoma; NTG, normal tension glaucoma; Tmax, maximum intraocular pressure; CCT, central corneal thickness; CDVA, corrected distance visual acuity; MD, mean deviation (Octopus perimetry)